UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): March 4, 2002


                                  ANTHEM, INC.
             (Exact name of registrant as specified in its charter)


    Indiana                      001-16751                        35-2145715
(State or other                 (Commission                     (IRS Employer
jurisdiction of                 File Number)                 Identification No.)
 incorporation)

                               120 Monument Circle
                             Indianapolis, IN 46204
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (317) 488-6000


                                       N/A
          (Former name or former address, if changed since last report)



Item 9. Regulation FD Disclosure

Officers of the Company expect to meet with securities analysts and investors
during the week of March 4, 2002. During these meetings, the officers expect to
confirm the Company's ability to meet the earnings expectations given in a press
release and conference call on February 6, 2002. A copy of that press release
was filed as Exhibit 99 to the Form 8-K filed by the Company with the Securities
and Exchange Commission on February 6, 2002.

The press release referred to above contains certain forward-looking
information. Words such as "expect(s)", "feel(s)", "believe(s)", "will", "may",
"anticipate(s)" and similar expressions are intended to identify forward-looking
statements. Such statements are subject to certain risks and uncertainties that
could cause actual results to differ materially from those projected. These
risks and uncertainties include: trends in health care costs and utilization
rates; our ability to secure sufficient premium rate increases; competitor
pricing below market trends of increasing costs; increased government regulation
of health benefits and managed care; significant acquisitions or divestitures by
major competitors; introduction and utilization of new prescription drugs and
technology; a downgrade in our financial strength ratings; litigation targeted
at health benefits companies; our ability to contract with providers consistent
with past practice; and general economic downturns. Readers are cautioned not to
place undue reliance on these forward-looking statements that speak only as of
the date hereof. Anthem undertakes no obligation to republish revised
forward-looking statements to reflect events or circumstances after the date
hereof or to reflect the occurrence of unanticipated events. Readers are also
urged to carefully review and consider the various disclosures made by Anthem,
found in Anthem's final Prospectus dated October 29, 2001, for the initial
public offering, and in periodic reports on Form 10-K, 10-Q and 8-K filed with
the Securities and Exchange Commission, which attempt to advise interested
parties of the factors which affect Anthem's business.

                                       -2-





                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: March 4, 2002

                                      ANTHEM, INC.


                                      By:      /s/      Michael L. Smith
                                         ---------------------------------------
                                         Name: Michael L. Smith
                                         Title: Executive Vice President and
                                                Chief Financial and Accounting
                                                Officer

                                       -3-